Skip to content

Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals

BHIVA: No clinical difference seen in first-line treatment response between B and non-B subtypes

Tropism test could show which patients would benefit from starting HIV treatment sooner

ART recommended for all with CD4 counts below 350, say South African doctors

SMART study reaffirms that HIV replication is harmful, even at CD4 counts above 350

Benefit of starting HIV treatment early outweighs the risk of toxicities, SMART study shows

Abacavir remains an equal first for people starting HIV treatment in US

Oral candidiasis is a reliable marker of low CD4 counts and HIV disease progression in Zimbabwean women

British HIV Association treatment guidelines open for public comment